Stephanie Pasas-Farmer, Ph.D.President and Founder at BioData Solutions, LLCSpeaker
Profile
Dr. Stephanie Pasas-Farmer is a biopharmaceutical scientist who offers R & D, regulatory and commercial consulting services to early stage pharmaceutical and biological drug development organizations in the field of bioanalysis. Her services include operational program management, data review and analysis, regulatory compliance planning in addition to market development guidance. Dr. Pasas-Farmer specializes in discovery and regulated bioanalysis of pharmaceutical, biologics and the hybrid technology antibody-drug conjugates. She brings extensive expertise in both quantitative and qualitative bioanalytical analysis using LC-MS/MS. With more than 20 years of bioanalytical chemistry and DMPK experience, Dr. Pasas-Farmer has held a range of scientific, business management and operational leadership positions across contract research and global pharmaceutical organizations as well as a start-up biotechnology company. Most recently, Dr. Pasas-Farmer served as Senior Director of Biologics Services for Frontage Laboratories where she led a team of scientists focused on the support of large molecule and antibody drug conjugate programs using LBA, LC-MS/MS, and cell based assays. Previously, she was Director of Client Services at Frontage. In this role, Dr. Pasas-Farmer served as a key liaison between clients and bioanalytical operations, holding responsibility for technical feasibility, proposal development and client support needs. Earlier career roles included management responsibility for quality control functions of bioanalytical laboratory operations, in addition to business development and research scientist positions. Dr. Pasas-Farmer earned her doctor of philosophy and master of science degrees with honors in pharmaceutical chemistry from the University of Kansas. Dr. Pasas-Farmer is a frequent contributor to peer-reviewed publications and industry conferences on current bioanalytical topics.
Agenda Sessions
Pharma Risk Tolerance in AI Usage
, 3:00pmView Session
